Targeted Therapy

Targeted Therapy is a type of cancer treatment that focuses on specific molecules or pathways involved in the growth and spread of cancer cells. Unlike traditional chemotherapy, which can affect both cancer and healthy cells, targeted therapy is designed to be more precise, minimizing damage to normal tissues. This precision makes targeted therapy an important approach in the treatment of various cancer types.

Here are key points about targeted therapy:

Molecular Targets: Targeted therapy drugs are designed to interact with specific molecules, proteins, or genes that are critical for cancer cell growth, survival, and spread. These targets can vary depending on the type of cancer.


Personalized Treatment: Targeted therapy is often personalized to the individual patient based on the specific genetic and molecular characteristics of their cancer. This is sometimes referred to as "precision medicine."


Types of Targeted Therapy:


Monoclonal Antibodies: These are engineered proteins that can recognize and bind to specific targets on cancer cells. They can block growth signals or trigger the immune system to attack the cancer cells.


Small Molecule Inhibitors: These drugs are small molecules that can enter cancer cells and interfere with specific molecules or pathways inside the cells. They may inhibit the enzymes responsible for cancer cell growth or angiogenesis (the formation of new blood vessels that feed tumors).


Signal Transduction Inhibitors: These drugs target the signaling pathways within cells that promote cancer growth. Examples include tyrosine kinase inhibitors.


Hormone Therapy: Targeted therapy can be used to block the effects of hormones in hormone-sensitive cancers, such as breast and prostate cancer.


Indications: Targeted therapy has been approved for various cancer types, including breast cancer, lung cancer, melanoma, leukemia, and many others. It is continuously evolving, with new drugs and treatments being developed.


Combination Therapy: Targeted therapy is often used in combination with other cancer treatments, such as chemotherapy, radiation therapy, and immunotherapy, to enhance the effectiveness of treatment.


Response Rates: Responses to targeted therapy can vary from patient to patient, and not all patients will benefit from these treatments. However, some individuals experience significant and durable responses.


Side Effects: Targeted therapy generally has fewer side effects compared to traditional chemotherapy. However, it can still lead to side effects specific to the targeted pathway or molecule being inhibited.


Monitoring and Follow-up: Patients receiving targeted therapy are closely monitored during treatment to assess its effectiveness and manage any side effects. Follow-up care is essential to evaluate the patient's response.

Targeted therapy represents a significant advancement in the treatment of cancer, allowing for more individualized and effective approaches. The choice of targeted therapy and its combination with other treatments is determined by the specific cancer diagnosis, stage, and the patient's overall health. Patients should have detailed discussions with their healthcare team to determine if targeted therapy is a suitable treatment option for their particular case.

Top of Form


Targeted Therapy